PT741574E - Forma galenica oral contendo colestipol como substancia veicular e substancias activas acidicas e processos para a sua preparacao - Google Patents

Forma galenica oral contendo colestipol como substancia veicular e substancias activas acidicas e processos para a sua preparacao

Info

Publication number
PT741574E
PT741574E PT95904434T PT95904434T PT741574E PT 741574 E PT741574 E PT 741574E PT 95904434 T PT95904434 T PT 95904434T PT 95904434 T PT95904434 T PT 95904434T PT 741574 E PT741574 E PT 741574E
Authority
PT
Portugal
Prior art keywords
active substances
pct
cholestiol
processes
preparation
Prior art date
Application number
PT95904434T
Other languages
English (en)
Inventor
Walter Muller
Karsten Cremer
Original Assignee
Lohmann Therapie Syst Lts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lohmann Therapie Syst Lts filed Critical Lohmann Therapie Syst Lts
Publication of PT741574E publication Critical patent/PT741574E/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/74Synthetic polymeric materials
    • A61K31/785Polymers containing nitrogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/14Quaternary ammonium compounds, e.g. edrophonium, choline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A61K47/585Ion exchange resins, e.g. polystyrene sulfonic acid resin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PT95904434T 1994-01-27 1994-12-08 Forma galenica oral contendo colestipol como substancia veicular e substancias activas acidicas e processos para a sua preparacao PT741574E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4402379A DE4402379C2 (de) 1994-01-27 1994-01-27 Orale Arzneiform mit sauren Wirkstoffen und Verfahren zu ihrer Herstellung

Publications (1)

Publication Number Publication Date
PT741574E true PT741574E (pt) 2002-11-29

Family

ID=6508812

Family Applications (1)

Application Number Title Priority Date Filing Date
PT95904434T PT741574E (pt) 1994-01-27 1994-12-08 Forma galenica oral contendo colestipol como substancia veicular e substancias activas acidicas e processos para a sua preparacao

Country Status (22)

Country Link
US (1) US5858344A (pt)
EP (1) EP0741574B1 (pt)
JP (1) JP3701971B2 (pt)
KR (1) KR100439311B1 (pt)
AT (1) ATE218371T1 (pt)
AU (1) AU697353B2 (pt)
CA (1) CA2182417C (pt)
CZ (1) CZ291006B6 (pt)
DE (2) DE4402379C2 (pt)
DK (1) DK0741574T3 (pt)
ES (1) ES2177622T3 (pt)
FI (1) FI116880B (pt)
HU (1) HU223317B1 (pt)
IL (1) IL112435A (pt)
MY (1) MY113340A (pt)
NO (1) NO963143L (pt)
NZ (1) NZ277777A (pt)
PL (1) PL315619A1 (pt)
PT (1) PT741574E (pt)
SK (1) SK97296A3 (pt)
WO (1) WO1995020394A1 (pt)
ZA (1) ZA95638B (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6403367B1 (en) * 1994-07-07 2002-06-11 Nanogen, Inc. Integrated portable biological detection system
DE19615820A1 (de) * 1996-04-06 1997-10-09 Holger Specht Zahnpflegemittel und Verfahren zu seiner Herstellung
US20030180249A1 (en) * 2002-03-18 2003-09-25 Khanna Satish Chandra Dosage forms for hygroscopic active ingredients
PL2561766T3 (pl) 2006-11-07 2018-06-29 The Procter And Gamble Company Kompozycje zawierające błonnik oraz sposoby ich wytwarzania i stosowania
US7767248B2 (en) * 2007-02-02 2010-08-03 Overly Iii Harry J Soft chew confectionary with high fiber and sugar content and method for making same
CA3222580A1 (en) 2021-06-07 2022-12-15 University Of Tsukuba Polymerized valproic acid and use thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ191762A (en) * 1978-10-19 1982-09-14 Merck & Co Inc Hypocholesteremic composition containing cholesterol synthesis inhibitor and anion exchange resin
US4221778A (en) * 1979-01-08 1980-09-09 Pennwalt Corporation Prolonged release pharmaceutical preparations
DE3366838D1 (en) * 1982-03-01 1986-11-20 Efamol Ltd Pharmaceutical composition
US4996047A (en) * 1988-11-02 1991-02-26 Richardson-Vicks, Inc. Sustained release drug-resin complexes
EP0409432A3 (en) * 1989-07-20 1991-12-11 Warner-Lambert Company Confectionery delivery system
CA2040865C (en) * 1990-05-15 2002-07-23 James L. Bergey Method for preventing, stabilizing or causing regression of atherosclerosis employing a combination of a cholesterol lowering drug and an ace inhibitor

Also Published As

Publication number Publication date
NZ277777A (en) 1997-01-29
FI962985A (fi) 1996-07-26
IL112435A0 (en) 1995-03-30
EP0741574A1 (de) 1996-11-13
SK97296A3 (en) 1997-04-09
NO963143L (no) 1996-09-24
EP0741574B1 (de) 2002-06-05
ES2177622T3 (es) 2002-12-16
MY113340A (en) 2002-01-31
HU9602041D0 (en) 1996-09-30
JP3701971B2 (ja) 2005-10-05
HUT74434A (en) 1996-12-30
KR100439311B1 (ko) 2005-08-17
AU697353B2 (en) 1998-10-01
AU1312795A (en) 1995-08-15
JPH09511488A (ja) 1997-11-18
DE59410133D1 (de) 2002-07-11
PL315619A1 (en) 1996-11-25
CA2182417A1 (en) 1995-08-03
DE4402379C2 (de) 1997-09-25
FI116880B (fi) 2006-03-31
FI962985A0 (fi) 1996-07-26
DK0741574T3 (da) 2002-09-23
KR970700505A (ko) 1997-02-12
HU223317B1 (hu) 2004-05-28
NO963143D0 (no) 1996-07-26
US5858344A (en) 1999-01-12
ATE218371T1 (de) 2002-06-15
DE4402379A1 (de) 1995-08-03
IL112435A (en) 1999-01-26
CZ291006B6 (cs) 2002-11-13
CA2182417C (en) 2007-04-17
WO1995020394A1 (de) 1995-08-03
CZ221396A3 (en) 1997-01-15
ZA95638B (en) 1995-10-25

Similar Documents

Publication Publication Date Title
HUP0101545A1 (hu) Peptideket időben elnyújtva kibocsátó gyógyászati készítmények és eljárás az előállításukra
AU5812400A (en) Carrier-drug conjugate
PL319833A1 (en) Compounds and composition for carrying active media
MA23608A1 (fr) Forme de dosage ii d'unite multiple en comprime
BR9406363A (pt) Composiçao farmacêutica processo para a preparaçao da mesma uso da mesma e processo para o tratamento de doenças relacionadas com o ácido gástrico
ATE146360T1 (de) Gonadotropin enthaltende gefriergetrocknete troepfen
AU5956398A (en) Remedies for lymphocytic tumors
YU8701A (sh) Nova oralna kompozicija
PT770384E (pt) Composicoes farmaceuticas solidas anidras para utilizacao vaginal
ES2016620B3 (es) Sistema para liberar medicamentos con bioaceptabilidad mejorada.
PT741574E (pt) Forma galenica oral contendo colestipol como substancia veicular e substancias activas acidicas e processos para a sua preparacao
DE69924304D1 (de) N-palmitoylethanolamid-enthaltende pharmazeutische zusammensetzungen und deren verwendung in der veterinärmedizin
BR9810433A (pt) Composições anti-helmìnticas
DE59510583D1 (de) Pharmazeutische zusammensetzung zur systemischen transdermalen verabreichung mit dem wirkstoff morphin-6-glucuronid
CA2205564A1 (en) Pharmaceutical compositions comprising nitric oxide-releasing biopolymers
DE3585936D1 (de) Biologisch aktive peptide, deren verfahren zur herstellung und pharmazeutische zusammensetzungen.
TH48567B (th) คอนจูเกตของอินเตอร์ฟีรอนโพลีเมอร์ที่ปรับปรุง
IT8723007A0 (it) Composizioni farmaceutiche per uso orale ad attivita' sequestrante degli acidi biliari contenenti colestiramina quale principio attivo, e procedimento per prepararle